litlas
Log inCreate account

Val J. Lowe

Active 1993–2025

305
Papers
35,129
Citations
107
h-index
275
i10-index

Citations

Citations per year for Val J. Lowe1940: 1 citations1967: 1 citations1977: 1 citations1994: 3 citations1995: 11 citations1996: 37 citations1997: 14 citations1998: 65 citations1999: 41 citations2000: 65 citations2001: 79 citations2002: 75 citations2003: 56 citations2004: 67 citations2005: 43 citations2006: 46 citations2007: 61 citations2008: 60 citations2009: 104 citations2010: 121 citations2011: 149 citations2012: 197 citations2013: 257 citations2014: 308 citations2015: 305 citations2016: 321 citations2017: 405 citations2018: 497 citations2019: 1,339 citations2020: 1,560 citations2021: 1,763 citations2022: 1,497 citations2023: 1,348 citations2024: 2,202 citations2025: 1,329 citations2026: 54 citations1941–1966: no citations, so these years are not shown1968–1976: no citations, so these years are not shown1978–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,907 citing papers, 28.9% of this breakdownUnited Kingdom: 1,438 citing papers, 8.5% of this breakdownChina: 1,050 citing papers, 6.2% of this breakdownSweden: 931 citing papers, 5.5% of this breakdownGermany: 928 citing papers, 5.5% of this breakdownNetherlands: 708 citing papers, 4.2% of this breakdownItaly: 703 citing papers, 4.1% of this breakdownCanada: 672 citing papers, 3.9% of this breakdownFrance: 625 citing papers, 3.7% of this breakdownSpain: 552 citing papers, 3.2% of this breakdownAustralia: 504 citing papers, 3% of this breakdownSwitzerland: 401 citing papers, 2.4% of this breakdown
0%28.9%Other 20.9%

Institutions

Fields

  • Medicine77.3%
  • Neuroscience11.7%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Psychology0.9%
  • Computer Science0.8%
  • Immunology and Microbiology0.4%
  • Other2.3%

Topics

  • Alzheimer's disease research and treatments14.7%
  • Dementia and Cognitive Impairment Research14.1%
  • Functional Brain Connectivity Studies3.9%
  • Medical Imaging Techniques and Applications2.9%
  • Parkinson's Disease Mechanisms and Treatments2.4%
  • Advanced Neuroimaging Techniques and Applications1.9%
  • Other60.1%

Coauthors

All papers

Open in search
  1. Performance of plasma phosphorylated tau 181 and 217 in the community

    Authors: Michelle M. Mielke, Jeffrey L. Dage, Ryan D. Frank, Alicia Algeciras‐Schimnich, David S. Knopman, Val J. Lowe, Guojun Bu, Prashanthi Vemuri, Jonathan Graff‐Radford, Clifford R. Jack, Ronald C. Petersen - Nature Medicine 2022 cited by 491

  2. Defining imaging biomarker cut points for brain aging and Alzheimer's disease

    Authors: Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M. Therneau, Val J. Lowe, David S. Knopman, Jeffrey L. Gunter, Matthew L. Senjem, David T. Jones, Kejal Kantarci, Mary M. Machulda, Michelle M. Mielke, Rosebud O. Roberts, Prashanthi Vemuri, Denise A. Reyes, Ronald C. Petersen - Alzheimer s & Dementia 2016 cited by 970

  3. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography

    Authors: Michelle M. Mielke, Clinton E. Hagen, Jing Xu, Xiyun Chai, Prashanthi Vemuri, Val J. Lowe, David Airey, David S. Knopman, Rosebud O. Roberts, Mary M. Machulda, Clifford R. Jack, Ronald C. Petersen, Jeffrey L. Dage - Alzheimer s & Dementia 2018 cited by 662

  4. Deep learning-based brain age prediction in normal aging and dementia

    Authors: Jeyeon Lee, Brian J. Burkett, Hoon‐Ki Min, Matthew L. Senjem, Emily S. Lundt, Hugo Botha, Jonathan Graff‐Radford, Leland R Barnard, Jeffrey L. Gunter, Christopher G. Schwarz, Kejal Kantarci, David S. Knopman, Bradley F. Boeve, Val J. Lowe, Ronald C. Petersen, Clifford R. Jack, David T. Jones - Nature Aging 2022 cited by 212

  5. Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

    Authors: Renaud La Joie, Nagehan Ayakta, William W. Seeley, Ewa Borys, Adam L. Boxer, Charles DeCarli, Vincent Doré, Lea T. Grinberg, Eric J. Huang, Ji‐Hye Hwang, Miloš D. Ikonomović, Clifford R. Jack, William J. Jagust, Lee‐Way Jin, William E. Klunk, Julia Kofler, Orit H. Lesman‐Segev, Samuel N. Lockhart, Val J. Lowe, Colin L. Masters, Chester A. Mathis, Catriona McLean, Bruce L. Miller, Daniel Mungas, James P. O’Neil, John Olichney, Joseph E. Parisi, Ronald C. Petersen, Howard J. Rosen, Christopher C. Rowe, Salvatore Spina, Prashanthi Vemuri, Victor L. Villemagne, Melissa E. Murray, Gil D. Rabinovici - Alzheimer s & Dementia 2018 cited by 326

  6. Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research

    Authors: Christina M. Moloney, Val J. Lowe, Melissa E. Murray - Alzheimer s & Dementia 2021 cited by 319

  7. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes

    Authors: Adam Fleisher, Michael J. Pontecorvo, Michael D. Devous, Ming‐Chi Lu, Anupa Arora, Stephen P. Truocchio, Patricia Aldea, Matthew Flitter, Tricia Locascio, Marybeth Devine, Andrew Siderowf, Thomas G. Beach, Thomas J. Montine, Geidy E. Serrano, Craig Curtis, Allison Perrin, Stephen Salloway, Misty Daniel, Charles Wellman, Abhinay D. Joshi, David J. Irwin, Val J. Lowe, William W. Seeley, Miloš D. Ikonomović, Joseph C. Masdeu, Ian Kennedy, Thomas S. Harris, Michael Navitsky, Sudeepti Southekal, Mark A. Mintun, A16 Study Investigators - JAMA Neurology 2020 cited by 443

  8. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes

    Authors: Michelle M. Mielke, Ryan D. Frank, Jeffrey L. Dage, Andreas Jeromin, Nicholas J. Ashton, Kaj Blennow, Thomas K. Karikari, Eugeen Vanmechelen, Henrik Zetterberg, Alicia Algeciras‐Schimnich, David S. Knopman, Val J. Lowe, Guojun Bu, Prashanthi Vemuri, Jonathan Graff‐Radford, Clifford R. Jack, Ronald C. Petersen - JAMA Neurology 2021 cited by 257

  9. Predicting amyloid PET and tau PET stages with plasma biomarkers

    Authors: Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, Daniel J. Figdore, Christopher G. Schwarz, Val J. Lowe, Vijay K. Ramanan, Prashanthi Vemuri, Michelle M. Mielke, David S. Knopman, Jonathan Graff‐Radford, Bradley F. Boeve, Kejal Kantarci, Petrice M. Cogswell, Matthew L. Senjem, Jeffrey L. Gunter, Terry M. Therneau, Ronald C. Petersen - Brain 2023 cited by 150

  10. Longitudinal tau PET in ageing and Alzheimer’s disease

    Authors: Clifford R. Jack, Heather J. Wiste, Christopher G. Schwarz, Val J. Lowe, Matthew L. Senjem, Prashanthi Vemuri, Stephen D. Weigand, Terry M. Therneau, D. S. Knopman, Jeffrey L. Gunter, David T. Jones, Jonathan Graff‐Radford, Kejal Kantarci, Rosebud O. Roberts, Michelle M. Mielke, Mary M. Machulda, Ronald C. Petersen - Brain 2018 cited by 461

  11. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging

    Authors: Rioghna R. Pittock, Jeremiah A. Aakre, Anna Castillo, Vijay K. Ramanan, Walter K. Kremers, Clifford R. Jack, Prashanthi Vemuri, Val J. Lowe, David S. Knopman, Ronald C. Petersen, Jonathan Graff-Radford, Maria Vassilaki - Neurology 2023 cited by 140

  12. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology

    Authors: Dror Shir, Jonathan Graff‐Radford, Ekaterina I. Hofrenning, Timothy G. Lesnick, Scott A. Przybelski, Val J. Lowe, David S. Knopman, Ronald C. Petersen, Clifford R. Jack, Prashanthi Vemuri, Alicia Algeciras‐Schimnich, Michelle R. Campbell, Nikki H. Stricker, Michelle M. Mielke - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2022 cited by 123

  13. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0

    Authors: Ian Law, Nathalie L. Albert, Javier Arbizu, Ronald Boellaard, Alexander Drzezga, Norbert Galldiks, Christian la Fougère, Karl‐Josef Langen, Egesta Lopci, Val J. Lowe, Jonathan McConathy, Harald H. Quick, Bernhard Sattler, David M. Schuster, Jörg-Christian Tonn, Michael Weller - European Journal of Nuclear Medicine and Molecular Imaging 2018 cited by 535

  14. Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice

    Authors: Ming Xu, Elizabeth W. Bradley, Megan Weivoda, Soyun M. Hwang, Tamar Pirtskhalava, Teresa Decklever, Geoffry L. Curran, Mikołaj Ogrodnik, Diana Jurk, Kurt O. Johnson, Val J. Lowe, Tamar Tchkonia, Jennifer J. Westendorf, James L. Kirkland - The Journals of Gerontology Series A 2016 cited by 351

  15. Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework

    Authors: Clifford R. Jack, Terry M. Therneau, Stephen D. Weigand, Heather J. Wiste, David S. Knopman, Prashanthi Vemuri, Val J. Lowe, Michelle M. Mielke, Rosebud O. Roberts, Mary M. Machulda, Jonathan Graff‐Radford, David T. Jones, Christopher G. Schwarz, Jeffrey L. Gunter, Matthew L. Senjem, Walter A. Rocca, Ronald C. Petersen - JAMA Neurology 2019 cited by 307

  16. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia

    Authors: Clifford R. Jack, Heather J. Wiste, Terry M. Therneau, Stephen D. Weigand, David S. Knopman, Michelle M. Mielke, Val J. Lowe, Prashanthi Vemuri, Mary M. Machulda, Christopher G. Schwarz, Jeffrey L. Gunter, Matthew L. Senjem, Jonathan Graff‐Radford, David T. Jones, Rosebud O. Roberts, Walter A. Rocca, Ronald C. Petersen - JAMA 2019 cited by 336

  17. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

    Authors: Clifford R. Jack, Val J. Lowe, Stephen D. Weigand, Heather J. Wiste, Matthew L. Senjem, David S. Knopman, Maria M. Shiung, Jeffrey L. Gunter, Bradley F. Boeve, Bradley J. Kemp, Michael P. Weiner, Ronald C. Petersen - Brain 2009 cited by 1,093

  18. White matter hyperintensities: relationship to amyloid and tau burden

    Authors: Jonathan Graff‐Radford, Eider M. Arenaza‐Urquijo, David S. Knopman, Christopher G. Schwarz, Robert D. Brown, Alejandro A. Rabinstein, Jeffrey L. Gunter, Matthew L. Senjem, Scott A. Przybelski, Timothy G. Lesnick, Chadwick P. Ward, Michelle M. Mielke, Val J. Lowe, Ronald C. Petersen, Walter K. Kremers, Kejal Kantarci, Clifford R. Jack, Prashanthi Vemuri - Brain 2019 cited by 249

  19. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting

    Authors: Rosebud O. Roberts, Jeremiah A. Aakre, Walter K. Kremers, Maria Vassilaki, David S. Knopman, Michelle M. Mielke, Rabe E. Alhurani, Yonas E. Geda, Mary M. Machulda, Preciosa M. Coloma, Barbara Schäuble, Val J. Lowe, Clifford R. Jack, Ronald C. Petersen - JAMA Neurology 2018 cited by 221

  20. Tau‐positron emission tomography correlates with neuropathology findings

    Authors: Val J. Lowe, Emily S. Lundt, Sabrina M. Albertson, Hoon‐Ki Min, Ping Fang, Scott A. Przybelski, Matthew L. Senjem, Christopher G. Schwarz, Kejal Kantarci, Bradley F. Boeve, David T. Jones, R. Ross Reichard, Jessica F. Tranovich, Fadi S. Hanna Al‐Shaikh, David S. Knopman, Clifford R. Jack, Dennis W. Dickson, Ronald C. Petersen, Melissa E. Murray - Alzheimer s & Dementia 2019 cited by 208

  21. Recommendations on the Use of 18F-FDG PET in Oncology

    Authors: James Fletcher, Benjamin Djulbegović, Heloisa P. Soares, Barry A. Siegel, Val J. Lowe, Gary H. Lyman, R. Edward Coleman, Richard L. Wahl, John C. Paschold, Norbert Avril, Lawrence H. Einhorn, W. Warren Suh, David J Samson, Dominique Delbeke, Mark Gorman, Anthony F. Shields - Journal of Nuclear Medicine 2008 cited by 1,089

  22. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes

    Authors: Jordan D. Marks, Jeremy A. Syrjanen, Jonathan Graff‐Radford, Ronald C. Petersen, Mary M. Machulda, Michelle R. Campbell, Alicia Algeciras‐Schimnich, Val J. Lowe, David S. Knopman, Clifford R. Jack, Prashanthi Vemuri, Michelle M. Mielke, for the Alzheimer’s Disease Neuroimaging Initiative - Alzheimer s Research & Therapy 2021 cited by 82

  23. Brain β-amyloid load approaches a plateau

    Authors: Clifford R. Jack, Heather J. Wiste, Timothy G. Lesnick, Stephen D. Weigand, David S. Knopman, Prashanthi Vemuri, V. Shane Pankratz, Matthew L. Senjem, Jeffrey L. Gunter, Michelle M. Mielke, Val J. Lowe, Bradley F. Boeve, Ronald C. Petersen - Neurology 2013 cited by 409

  24. Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology

    Authors: Beatriz Gomez Perez‐Nievas, Thor D. Stein, Hwan‐Ching Tai, Oriol Dols‐Icardo, Thomas C. Scotton, Isabel Barroeta-Espar, Leticia Fernandez-Carballo, Estibaliz Lopez de Munain, Jesus Perez, Marta Marquié, Alberto Serrano‐Pozo, Mathew P. Frosch, Val J. Lowe, Joseph E. Parisi, Ronald C. Petersen, Miloš D. Ikonomović, Oscar L. López, William E. Klunk, Bradley T. Hyman, Teresa Gómez‐Isla - Brain 2013 cited by 381